Skip to content

The Effect of Perioperative Vitamin C Supplementation on Postoperative Delirium and Intraoperative Blood Selenium Levels in Older Patients: A Randomized Controlled Trial

The Effect of Perioperative Vitamin C Supplementation on Postoperative Delirium and Intraoperative Blood Selenium Levels in Older Patients: A Randomized Controlled Trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119017
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-02-13
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postsurgical Delirium

Interventions

Ascorbic Acid Group:Intravenous Ascorbic Acid

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >=65 years old; 2. ASA health status at levels II-III; 3. Patients undergoing their first orthopedic surgery under general anesthesia with combined intravenous-inhalation technique; 4. Have basic communication skills and can cooperate with postoperative cognitive assessment; 5. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. For those allergic to ascorbic acid or with abnormal oxalate metabolism (urinary oxalate > 40mg/24h); 2. Patients with renal insufficiency (eGFR 38.5?, abnormal white blood cell count in blood routine); 9. Patients with acute infection before the surgery (such as pulmonary infection, urinary system infection, etc., based on clinical indicators such as body temperature > 38.5?, abnormal white blood cell count in blood routine); 10. Subjects who voluntarily withdraw the informed consent form and do not wish to continue participating in the study; 11. During the study, serious adverse reactions or complications occur, such as ascorbic acid allergic reactions (rash, breathing difficulties, etc.), intraoperative massive bleeding, severe infection, etc., and the investigator assesses that continuing to participate in the study may endanger the safety of the subjects.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium;

Secondary

MeasureTime frame
The selenium (Se) content in plasma and the degree of selenium (Se) change in blood;Serum glutathione peroxidase 4;Serum Selenium Protein P;The ratio of reduced glutathione to oxidized glutathione;Postoperative Pain Assessment Scales;serum C-reactive protein;serum Ascorbic Acid level;Serum reactive oxygen species;The severity of postoperative delirium;

Countries

China

Contacts

Public ContactLi Ping

The First Affiliated Hospital of Chongqing Medical University

anesolee@foxmail.com+86 130 6233 7738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026